Lymph node ratio-dependent prognosis stratification and postoperative radiotherapy utilization in T1-2N1 oral cavity carcinoma
- PMID: 35568286
- DOI: 10.1016/j.radonc.2022.05.009
Lymph node ratio-dependent prognosis stratification and postoperative radiotherapy utilization in T1-2N1 oral cavity carcinoma
Abstract
Objective: Pathological T1-2N1 oral cavity squamous cell carcinoma (pT1-2N1 OCSCC) is a setting with intermediate prognosis whilst without consensus regarding the utilization of postoperative radiotherapy (PORT). This study aimed to investigate the prognostic value of lymph node ratio (LNR) and to further examine its clinical validity for guiding PORT in pT1-2N1 OCSCC.
Methods: OCSCC patients who received surgery between 2010 and 2015 with at least 6 lymph nodes dissection were extracted from the Surveillance, Epidemiology and End Results (SEER) database. Time-dependent receiver operating characteristic (ROC) analysis was used to identify the optimal cutoff of LNR. Multivariable Cox regression analysis was employed to assess the prognostic value of LNR. Impact of PORT was evaluated in respective subgroups stratified by LNR.
Results: A total of 870 OCSCC patients with pT1-2N1 diseases were eligible for analysis. The 5-year overall survival (OS) and disease-specific survival (DSS) was 57.2% and 67.9% respectively. Time-dependent ROC analyses for OS and DSS concordantly revealed 5.5% as the optimal cutoff of LNR. Significantly higher risks of death (HR = 1.610, 95% CI: 1.139-2.276) and disease-specific death (HR = 1.731, 95% CI: 1.101-2.723) were unveiled in patients with LNR > 5.5%. PORT related improvement on OS (5-year rate: 57.6% vs. 47.3%, p = 0.095) and DSS (5-year rate: 71.0% vs. 53.8%, p = 0.030) was only found in LNR > 5.5% subgroup.
Conclusions: LNR > 5.5% is indicative of inferior outcome in pT1-2N1 OCSCC, warranting the utilization of PORT in this sub-setting.
Keywords: AJCC stage; Lymph node ratio; Oral cavity; Postoperative radiotherapy; Prognosis; Squamous cell carcinoma.
Copyright © 2022 Elsevier B.V. All rights reserved.
Similar articles
-
Use of lymph node ratio to guide clinical decision-making concerning adjuvant radiotherapy in pT1-2N1 rectal cancer.Int J Colorectal Dis. 2023 May 6;38(1):115. doi: 10.1007/s00384-023-04415-8. Int J Colorectal Dis. 2023. PMID: 37148381
-
Re-evaluating Lymph Node Yield, Lymph Node Ratio, and the number of metastatic nodes as prognostic factors in oral cavity squamous cell carcinoma.Oral Oncol. 2025 Jul;166:107391. doi: 10.1016/j.oraloncology.2025.107391. Epub 2025 May 22. Oral Oncol. 2025. PMID: 40408842
-
Prognostic value of positive lymph node ratio in oral cavity squamous cell carcinoma after neoadjuvant treatment: a retrospective real-world study.Sci Rep. 2025 May 22;15(1):17785. doi: 10.1038/s41598-025-03048-x. Sci Rep. 2025. PMID: 40404864 Free PMC article.
-
Lymph node ratio (LNR) and lymph node yield (LNY) in head and neck cancer: A systematic review and meta-analysis.J Craniomaxillofac Surg. 2025 Apr;53(4):290-300. doi: 10.1016/j.jcms.2024.11.016. Epub 2024 Dec 20. J Craniomaxillofac Surg. 2025. PMID: 39706715
-
Prognostic value of lymph node ratio in laryngeal and hypopharyngeal squamous cell carcinoma: a systematic review and meta-analysis.J Otolaryngol Head Neck Surg. 2020 May 29;49(1):31. doi: 10.1186/s40463-020-00421-w. J Otolaryngol Head Neck Surg. 2020. PMID: 32471483 Free PMC article.
Cited by
-
Prognostic factors in surgically treated tongue squamous cell carcinoma in stage T1-2N0-1M0: A retrospective analysis.Cancer Med. 2024 Feb;13(3):e7016. doi: 10.1002/cam4.7016. Cancer Med. 2024. PMID: 38400675 Free PMC article.
-
Use of lymph node ratio to guide clinical decision-making concerning adjuvant radiotherapy in pT1-2N1 rectal cancer.Int J Colorectal Dis. 2023 May 6;38(1):115. doi: 10.1007/s00384-023-04415-8. Int J Colorectal Dis. 2023. PMID: 37148381
-
Analysis of factors associated with the prognosis of papillary thyroid cancer and the construction of a survival model.Cancer Med. 2023 Apr;12(7):7868-7876. doi: 10.1002/cam4.5555. Epub 2022 Dec 22. Cancer Med. 2023. PMID: 36560883 Free PMC article.
-
The prognostic value of lymphatic metastatic size in head and neck squamous cell carcinoma.Eur Arch Otorhinolaryngol. 2024 Jan;281(1):387-395. doi: 10.1007/s00405-023-08199-z. Epub 2023 Sep 8. Eur Arch Otorhinolaryngol. 2024. PMID: 37682351
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical